A detailed history of Massmutual Trust CO Fsb transactions in Cassava Sciences Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 29 shares of SAVA stock, worth $73. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 29 -0.0%
Holding current value
$73
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$9.57 - $35.08 $277 - $1,017
29 New
29 $0
Q3 2022

Oct 07, 2022

BUY
$16.33 - $51.06 $163 - $510
10 New
10 $0
Q2 2022

Jul 07, 2022

SELL
$17.22 - $38.47 $223 - $500
-13 Closed
0 $0
Q1 2022

Apr 08, 2022

BUY
$32.6 - $53.05 $423 - $689
13 New
13 $0

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $101M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.